Labcorp Debt to Equity Ratio 2010-2024 | LH

Current and historical debt to equity ratio values for Labcorp (LH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Labcorp debt/equity for the three months ending March 31, 2024 was 0.39.
Labcorp Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $8.57B $7.96B 1.08
2023-12-31 $8.85B $7.88B 1.12
2023-09-30 $9.01B $7.87B 1.15
2023-06-30 $8.93B $8.79B 1.02
2023-03-31 $9.86B $10.34B 0.95
2022-12-31 $10.06B $10.10B 1.00
2022-09-30 $9.73B $10.09B 0.96
2022-06-30 $10.00B $10.40B 0.96
2022-03-31 $10.01B $10.72B 0.93
2021-12-31 $10.11B $10.27B 0.98
2021-09-30 $10.34B $10.53B 0.98
2021-06-30 $10.17B $10.25B 0.99
2021-03-31 $10.40B $10.02B 1.04
2020-12-31 $10.64B $9.44B 1.13
2020-09-30 $10.50B $8.24B 1.27
2020-06-30 $10.50B $7.35B 1.43
2020-03-31 $10.28B $7.02B 1.46
2019-12-31 $10.48B $7.57B 1.39
2019-09-30 $10.62B $7.23B 1.47
2019-06-30 $10.60B $7.14B 1.48
2019-03-31 $9.86B $7.11B 1.39
2018-12-31 $9.21B $6.97B 1.32
2018-09-30 $9.41B $7.25B 1.30
2018-06-30 $9.47B $7.04B 1.35
2018-03-31 $9.85B $6.98B 1.41
2017-12-31 $9.87B $6.80B 1.45
2017-09-30 $10.57B $6.13B 1.73
2017-06-30 $9.02B $5.88B 1.54
2017-03-31 $8.78B $5.65B 1.55
2016-12-31 $8.74B $5.51B 1.59
2016-09-30 $8.96B $5.52B 1.62
2016-06-30 $8.89B $5.31B 1.67
2016-03-31 $9.24B $5.17B 1.79
2015-12-31 $9.16B $4.95B 1.85
2015-09-30 $9.51B $4.91B 1.94
2015-06-30 $9.70B $4.77B 2.03
2015-03-31 $9.63B $4.52B 2.13
2014-12-31 $4.48B $2.82B 1.59
2014-09-30 $4.46B $2.77B 1.61
2014-06-30 $4.49B $2.66B 1.69
2014-03-31 $4.49B $2.50B 1.80
2013-12-31 $4.48B $2.49B 1.80
2013-09-30 $4.12B $2.57B 1.61
2013-06-30 $3.93B $2.66B 1.48
2013-03-31 $3.79B $2.78B 1.37
2012-12-31 $4.08B $2.72B 1.50
2012-09-30 $4.10B $2.72B 1.51
2012-06-30 $3.47B $2.63B 1.32
2012-03-31 $3.53B $2.60B 1.36
2011-12-31 $3.61B $2.50B 1.44
2011-09-30 $3.51B $2.54B 1.38
2011-06-30 $3.59B $2.58B 1.39
2011-03-31 $3.80B $2.40B 1.58
2010-12-31 $3.72B $2.47B 1.51
2010-09-30 $2.78B $2.27B 1.22
2010-06-30 $2.75B $2.21B 1.25
2010-03-31 $2.78B $2.16B 1.29
2009-12-31 $2.73B $2.11B 1.30
2009-09-30 $2.80B $2.03B 1.38
2009-06-30 $2.70B $2.01B 1.35
2009-03-31 $3.01B $1.82B 1.66
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.830B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00